Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ankie M.T. van der Velden"'
Autor:
Epie Boven, Harm van Tinteren, Aafke H. Honkoop, Johanneke E.A. Portielje, Ankie M.T. van der Velden, Joan van den Bosch, Monique M.E.M. Bos, Agnes Jager, Nienke M. Nota, Siu W. Lam
Purpose: We examined whether pretreatment levels of angiogenesis- or hypoxia-related proteins and their changes after one cycle of first-line bevacizumab-based therapy were associated with response, PFS, or OS in patients with metastatic breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba4f07774af27b81ffc97bcaf6441ec
https://doi.org/10.1158/1078-0432.c.6524210.v1
https://doi.org/10.1158/1078-0432.c.6524210.v1
Autor:
Epie Boven, Harm van Tinteren, Aafke H. Honkoop, Johanneke E.A. Portielje, Ankie M.T. van der Velden, Joan van den Bosch, Monique M.E.M. Bos, Agnes Jager, Nienke M. Nota, Siu W. Lam
Supplementary Table 1. Clinical outcome of original trial population and biomarker population Supplementary Table 2. Baseline plasma protein levels vs baseline patient and tumor characteristics Supplementary Table 3. Spearman Rho correlation coeffici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92209ee6113aed3e189e26a6148dad36
https://doi.org/10.1158/1078-0432.22459391
https://doi.org/10.1158/1078-0432.22459391
Autor:
Ellen van der Vlies, Maartje Los, Joyce M. van Dodewaard, Lisette M. Vernooij, Martijn Intven, Marianne Smits, Ankie M.T. van der Velden, Marije E. Hamaker, Peter G. Noordzij, Willem Jan W Bos, Eric P.A. van Dongen, Geraldine R. Vink, Marijn Takkenberg, Anke B. Smits
Publikováno v:
Journal of Geriatric Oncology. 13:74-81
Background Health related quality of life (HRQL) is an important outcome measure in geriatric oncology. Surgery is the main treatment for colorectal cancer (CRC) but has been associated with a loss of HRQL in older patients. This study aimed to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0b48c5dbeb05283e8f9001442c499c
https://doi.org/10.1016/j.jgo.2021.08.005
https://doi.org/10.1016/j.jgo.2021.08.005
Autor:
Peter Nieboer, Petra H.M. Peeters, Sophie A Kurk, Marion Jourdan, Cornelis J. A. Punt, Anne M. May, Miriam Koopman, Aafke H. Honkoop, Bram Dorresteijn, Jeroen W.G. Derksen, Robert S. De Jong, Ankie M.T. van der Velden
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 919-928 (2020)
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, 11(4), 919-928. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, 11(4), 919-928. Wiley-Blackwell
Background Skeletal muscle mass (SMM) loss is common in metastatic colorectal cancer (mCRC) patients and associated with poor clinical outcomes, including increased treatment‐related toxicities and reduced survival. Muscle loss may contribute to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160def76545b4b9c423ed3a1ffe104b0
https://doaj.org/article/58f882ec34e24402b6d47894a4ed50df
https://doaj.org/article/58f882ec34e24402b6d47894a4ed50df
Autor:
Seyed M. Qaderi, Joost A.G. van der Heijden, Rob H.A. Verhoeven, Johannes H.W. de Wilt, Jose A.E. Custers, Geerard L. Beets, Eric J.Th. Belt, Maaike Berbée, Frederique H. Beverdam, Ruud Blankenburgh, Peter Paul L.O. Coene, Jan Willem B. de Groot, Ignace H.J.T. de Hingh, Aad I. de Vos, Jan Willem T. Dekker, Frans L.G. Erdkamp, Annebeth W. Haringhuizen, Helgi H. Helgason, Mathijs P. Hendriks, Ronald Hoekstra, Jan N.M. Ijzermans, Jan Jansen, Frank W.H. Kloppenberg, Maartje Los, Martijn R. Meijerink, Leonie J.M. Mekenkamp, Peter Nieboer, Koen C.M.J. Peeters, Natascha A.J.B. Peters, Marco B. Polée, Johannes F.M. Pruijt, Patricia Quarles van Ufford-Mannesse, Ron C. Rietbroek, Anandi H.W. Schiphorst, Arjan Schouten van der Velden, Ruud W.M. Schrauwen, Mark P.S. Sie, Lieke Simkens, Dirkje W. Sommeijer, Dirk J.A. Sonneveld, Leontine E.A. Spierings, Hein B.A.C. Stockmann, Koen Talsma, Albert J. ten Tije, Frederiek Terheggen, Manuel L.R. Tjin-A-Ton, Liselot B.J. Valkenburg-van Iersel, Hester van Cruijsen, Ankie M.T. van der Velden, Joyce M. van Dodewaard-de Jong, Anja U.G. van Lent, Theo van Voorthuizen, Maarten Vermaas, Wouter J. Vles, Jeroen F.J. Vogelaar, David D.E. Zimmerman
Publikováno v:
European Journal of Cancer, 158, 144-155. Elsevier Limited
European Journal of Cancer, 158, 144-155. Pergamon
European Journal of Cancer, 158, 144-155. Elsevier Ltd.
European Journal of Cancer, 158, pp. 144-155
PLCRC study group 2021, ' Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer : A population-based study ', European Journal of Cancer, vol. 158, pp. 144-155 . https://doi.org/10.1016/j.ejca.2021.08.050
European Journal of Cancer, 158, 144-155
European Journal of Cancer, 158, 144-155. Pergamon
European Journal of Cancer, 158, 144-155. Elsevier Ltd.
European Journal of Cancer, 158, pp. 144-155
PLCRC study group 2021, ' Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer : A population-based study ', European Journal of Cancer, vol. 158, pp. 144-155 . https://doi.org/10.1016/j.ejca.2021.08.050
European Journal of Cancer, 158, 144-155
Background The aim of this nationwide cohort study was to examine the course of symptoms and trajectories of health-related quality of life (HR-QoL) and psychological distress during follow-up and to identify vulnerable patients. Methods Patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2f6e79edc9a5d65d0698ea0d020a5de
https://pure.amc.nl/en/publications/trajectories-of-healthrelated-quality-of-life-and-psychological-distress-in-patients-with-colorectal-cancer(0cca2467-3283-4075-9c77-4e6cefda0b77).html
https://pure.amc.nl/en/publications/trajectories-of-healthrelated-quality-of-life-and-psychological-distress-in-patients-with-colorectal-cancer(0cca2467-3283-4075-9c77-4e6cefda0b77).html
Autor:
Gerrit Jan Veldhuis, Edith B. van Druten, Cathrien S. Tromp-van Driel, Ronald C. Rietbroek, Gerty J. de Klerk, Annebeth W. Haringhuizen, Theo van Voorthuizen, J. E. Vincent, Manuel L. R. Tjin-A-Ton, Anne M. May, Ankie M.T. van der Velden, Geraldine R. Vink, Brigitte C. M. Haberkorn, J. Cornelis B. Hunting, Joyce M. van Dodewaard-de Jong, R. Hoekstra, Lieke H.J. Simkens, Sandra D. Bakker, Patricia Quarles van Ufford-Mannesse, Jeanine M.L. Roodhart, Geert-Jan Creemers, Marjan A. van Dijk, Marco B. Polee, G. Emerens Wensink, Cornelis J. A. Punt, Daan ten Bokkel Huinink, Marloes A. G. Elferink, Bea Tanis, Franchette W P J van den Berkmortel, Henk M.W. Verheul, Danielle Mathijssen-van Stein, Miriam Koopman, Hanneke J. H. M. J. Vestjens, Sandra A Radema, J.F.M. Pruijt, Monique M. Troost, Onno Kranenburg, Jan Willem B. de Groot, Anke J. M. van der Pas, Agnes J. van de Wouw, Emile D. Kerver, Patricia A. H. Hamers, Linda Mol
Publikováno v:
British Journal of Cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0
BackgroundMetastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0117d001dca85f91775734a7c4208f2d
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4
Autor:
Miriam Koopman, Felix E de Jongh, Ankie M.T. van der Velden, Bram Dorresteijn, Sophie A Kurk, Pim A. de Jong, Geert-Jan Creemers, Petra H.M. Peeters, Frans L. G. Erdkamp, Marion Jourdan, Anne M May, Peter A M Kint, Boelo J Poppema, Lieke H.J. Simkens, Manuel L. R. Tjin-A-Ton, B.C. Tanis, Cornelis J. A. Punt, Sandra A Radema
Publikováno v:
Cancer Medicine, 9(3), 1033. John Wiley and Sons Ltd
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Cancer medicine, 9(3), 1033-1043. John Wiley and Sons Ltd
Cancer Medicine, 9, 1033-1043
Cancer Medicine, 9, 3, pp. 1033-1043
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1033-1043 (2020)
Cancer medicine, 9(3), 1033-1043. John Wiley and Sons Ltd
Cancer Medicine, 9, 1033-1043
Cancer Medicine, 9, 3, pp. 1033-1043
Background Low skeletal muscle index (SMI) in metastatic colorectal cancer (mCRC) patients is associated with poor outcomes. The prognostic impact of SMI changes during consecutive palliative systemic treatments is unknown. Methods This is a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9423fcb999920710eadfa5693d7cdcb6
https://dspace.library.uu.nl/handle/1874/395432
https://dspace.library.uu.nl/handle/1874/395432
Autor:
Cornelis J. A. Punt, Manuel L. R. Tjin-A-Ton, Petra H.M. Peeters, B.C. Tanis, Ankie M.T. van der Velden, Felix E de Jongh, Bram Dorresteijn, Peter A M Kint, Pim de Jong, Geert-Jan Creemers, Sophie A Kurk, Rebecca K. Stellato, Miriam Koopman, A. M. May, Lieke H.J. Simkens, Marion Jourdan, Frans L. G. Erdkamp
Publikováno v:
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 10(4), 803-813. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle, Vol 10, Iss 4, Pp 803-813 (2019)
Journal of Cachexia, Sarcopenia and Muscle, 10(4), 803. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, Vol 10, Iss 4, Pp 803-813 (2019)
Journal of Cachexia, Sarcopenia and Muscle, 10(4), 803. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle
Background Increasing evidence suggests that severe skeletal muscle index (SMI) loss (sarcopenia) is associated with poor overall survival in metastatic colorectal cancer patients, but its mechanisms are unknown. We recently found, using data of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd37faf96655e2b511007c5e1839fd2
https://pure.amc.nl/en/publications/skeletal-muscle-mass-loss-and-doselimiting-toxicities-in-metastatic-colorectal-cancer-patients(2887e29c-c41f-4f79-8562-1e59ae142ea7).html
https://pure.amc.nl/en/publications/skeletal-muscle-mass-loss-and-doselimiting-toxicities-in-metastatic-colorectal-cancer-patients(2887e29c-c41f-4f79-8562-1e59ae142ea7).html
Autor:
Erik W. Muller, Cornelis J. A. Punt, Ankie M.T. van der Velden, Robbert J. van Alphen, Theo van Voorthuizen, Linda Mol, Johannes J.M. Kwakman, Johan M van Rooijen, Yes A J van de Wouw, Albert J. ten Tije, Mathijs P. Hendriks, Miriam Koopman, Marco B. Polee, Geert-Jan Creemers, Erik van Werkhoven, Maartje Los, Lieke H.J. Simkens
Publikováno v:
Clinical colorectal cancer, 18(2), e229-e230. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d747df5e9f531a7f07e047ad7c211cb
https://doi.org/10.1016/j.clcc.2019.01.002
https://doi.org/10.1016/j.clcc.2019.01.002
Autor:
Hans J Braun, Siu W. Lam, Steffen M de Groot, Ankie M.T. van der Velden, Judith R. Kroep, Johanneke E.A. Portielje, Joep Douma, Carolien H. Smorenburg, Aafke H. Honkoop, Monique M.E.M. Bos, Nienke M. Nota, Jetske M. Meerum Terwogt, Joan van den Bosch, Frank Jeurissen, Johanna Mgh van Riel, Bea Tanis, Johan Berends, Epie Boven, Sabine C. Linn, Marien O den Boer, Harm van Tinteren, Maartje Los, Agnes Jager
Publikováno v:
Cancer Research. 75:P3-06
Background The phase II ATX trial aimed at evaluating safety and efficacy of first-line AT or ATX for HER2-negative LR/MBC (NTR1348; BOOG 2006-06). Plasma samples were collected for investigation of circulating proteins involved in angiogenesis and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f92b328b9ca5c7d59d709c64ec582810
https://doi.org/10.1158/1538-7445.sabcs14-p3-06-09
https://doi.org/10.1158/1538-7445.sabcs14-p3-06-09